Literature DB >> 20380160

MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer.

T A Bogush1, E A Dudko, E A Bogush, M V Tikhomirov, V Yu Kirsanov, M I Davydov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20380160     DOI： 10.1134/s1607672910010114

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  7 in total

1.  A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer.

Authors:  E A Bogush; A B Ravcheeva; T A Bogush; T N Zabotina; Z G Kadagidze; M I Davydov
Journal:  Dokl Biochem Biophys       Date:  2007 Mar-Apr       Impact factor: 0.788

2.  Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth.

Authors:  T Frogne; J S Jepsen; S S Larsen; C K Fog; B L Brockdorff; A E Lykkesfeldt
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

3.  Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.

Authors:  Bolin Liu; Dalia Ordonez-Ercan; Zeying Fan; Susan M Edgerton; Xiaohe Yang; Ann D Thor
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

4.  Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.

Authors:  Yamei Zhou; Serenella Eppenberger-Castori; Corina Marx; Christina Yau; Gary K Scott; Urs Eppenberger; Christopher C Benz
Journal:  Int J Biochem Cell Biol       Date:  2005-05       Impact factor: 5.085

5.  Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients.

Authors:  Liane M McGlynn; Tove Kirkegaard; Joanne Edwards; Sian Tovey; David Cameron; Chris Twelves; John M S Bartlett; Timothy G Cooke
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

6.  Antiestrogens and steroid hormones: substrates of the human P-glycoprotein.

Authors:  U S Rao; R L Fine; G A Scarborough
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858

7.  Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

Authors:  R Callaghan; C F Higgins
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640
  7 in total
  1 in total

Review 1.  Tamoxifen non-estrogen receptor mediated molecular targets.

Authors:  Tatiana Bogush; Evgeny Dudko; Elena Bogush; Boris Polotsky; Sergei Tjulandin; Mikhail Davydov
Journal:  Oncol Rev       Date:  2012-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.